Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Identification of Genes with Rare Loss of Function Variants Associated with Aggressive Prostate Cancer and Survival

European Urology Oncology(2024)10.1016/j.euo.2024.02.003Source: DataRank Database

Identification of Genes with Rare Loss of Function Variants Associated with Aggressive Prostate Cancer and Survival is a research paper published in European Urology Oncology (2024). On theSindex it has a DataRank of 0.345. It has been cited 9 times.

N/A

0.345DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 2.77)OA: hybridTopics (34)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.345

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (17)

Tokhir Dadaev ORCID,Mark N. Brook ORCID,Sarah Wakerell,Koveela Govindasami,Reshma Rageevakumar

Live enrichment

PubMed:38458890 PMC:PMC12124132 OpenAlex:https://openalex.org/W4392542795

NCI NIH HHS

Grant: U01 CA261339

NCI NIH HHS

Grant: R01 CA289492

NCI NIH HHS

Grant: U01 CA257328

NCI NIH HHS

Grant: R00 CA246063

NCI NIH HHS

Grant: R01 CA196931

Cancer Research UK

Grant: C5047/A17528

Cancer Research UK

NIH

FWCI

2.77

Citation Percentile

0.9%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.euo.2024.02.003

publisherhttps://doi.org/10.1016/j.euo.2024.02.003

publisherhttps://api.elsevier.com/content/article/PII:S2588931124000476?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2588931124000476?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38458890

Fields of Study

Prostate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchBRCA gene mutations in cancerMaleHumansProstatic NeoplasmsProstateGenes, BRCA2MutationProstate Cancer, Hereditary, 7

MeSH Terms

HumansMaleMutationProstateProstatic NeoplasmsGenes, BRCA2

Keywords

MedicineProstate cancerLoss functionIdentification (biology)GeneProstateCancerOncologyInternal medicineBioinformaticsGeneticsComputational biologyPhenotypeBiologyDna Repair GenesAggressive Prostate CancerProstate Cancer SurvivalGermline Prognostic Markers

Sustainable Development Goals

SDG 0: Good health and well-being